SCHEMBL6668272

SCHEMBL6668272

NC(C(=O)N1CCCC1)[C@@H]1CCC[C@@H]1O

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 20/20 0.58
▸ DPP7 Q9UHL4 15/20 0.58
▸ PREP P48147 1/20 0.39
▸ KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6668270 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL7117336 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL6668388 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL6668660 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL6668231 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL6668393 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL7129714 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL7123215 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL6668659 1.00 DPP4 (0.58) DPP4DPP7PREPKCNH2
SCHEMBL7124849 0.98 DPP4 (0.57) DPP4DPP7PREPKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1270562-B1 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof SERVIER LAB (FR) 2004-09-22 — — EP claimed
US-6593312-B2 Hypoglycemic agents; antidiabetic agents; dietetics LES LABORATOIRES SERVIER (FR) 2003-07-15 — — US claimed
US-20030004138-A1 Cyclic a-amino-y hydroxyamide compounds LES LABORATOIRES SERVIER (FR) 2003-01-02 — — US claimed
EP-1270562-A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof Les Laboratoires Servier (FR) 2003-01-02 — — EP claimed
EP-1270562-B1 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof SERVIER LAB (FR) 2004-09-22 — — EP disclosed
US-6593312-B2 Hypoglycemic agents; antidiabetic agents; dietetics LES LABORATOIRES SERVIER (FR) 2003-07-15 — — US disclosed
US-20030004138-A1 Cyclic a-amino-y hydroxyamide compounds LES LABORATOIRES SERVIER (FR) 2003-01-02 — — US disclosed
EP-1270562-A2 Cyclic alpha-amino-gamma-hydroxy-amides, process for their preparation and pharmaceutical compositions thereof Les Laboratoires Servier (FR) 2003-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004138-A1 Cyclic a-amino-y hydroxyamide compounds GPR119, SLC5A1, SLC5A2 DPP4 609/4885DPP7 1821/4885PREP 2240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback